INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

A probiotic drink with Lactobacillus casei DN 114001 was linked to lower AAD incidence and confirmed preventive effects in a pilot trial.

In an observational study of 258 patients with infections receiving antibiotics, 107 were offered a probiotic drink containing Lactobacillus casei DN 114001 b.i.d. AAD incidence was 6.5% in the probiotic group versus 28.4% in controls, and duration was 1.7 ± 1.1 versus 3.1 ± 2.1 days. A second randomized controlled pilot study of 60 patients directly compared two probiotic drinks and confirmed the preventive effect for L. casei DN 114001, but found no advantage for a drink containing Lactobacillus casei Shirota.

Study type
Observational study followed by a randomized controlled pilot trial
Who was studied
258 patients with infections in an observational study; 60 patients in a randomized pilot trial
What was measured
Incidence and duration of antibiotic-associated diarrhea (AAD), and cost-efficiency

THE PAPER

Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea.

Dietrich CG, Kottmann T, Alavi M. World J Gastroenterol, 2014.

PubMed 25400470 ↗DOI 10.3748/wjg.v20.i42.15837 ↗

Gut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.